Amedisys, Inc. (Amedisys) is a provider of home health and hospice services. The Company offers home health services to the chronic, co-morbid, aging American population. The Company operates through three segments: home health, hospice and personal care. The Company's home health segment delivers a range of services in the homes of individuals recovering from surgery, have a chronic disability or terminal illness or need assistance with completing important personal tasks. The Company's hospice segment provides palliative care and comfort to terminally ill patients and their families. The Company's personal care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 330 Medicare-certified home healthcare centers, over 80 Medicare-certified hospice care centers and approximately nine personal-care care centers in over 30 states within the United States, the District of Columbia and Puerto Rico.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Home Health Care
- Sub-Industry: Health Care Services
- Exchange: NASDAQ
- Symbol: AMED
- CUSIP: 02343610
- Previous Close: $48.40
- 50 Day Moving Average: $46.14
- 200 Day Moving Average: $45.03
- 52-Week Range: $34.58 - $55.16
- Trailing P/E Ratio: 39.87
- Foreward P/E Ratio: 24.46
- P/E Growth: 1.47
- Market Cap: $1.64B
- Outstanding Shares: 33,569,000
- Beta: 1.43
- Net Margins: 2.93%
- Return on Equity: 11.94%
- Return on Assets: 7.17%
Companies Related to Amedisys:
- Debt-to-Equity Ratio: 0.20%
- Current Ratio: 1.06%
- Quick Ratio: 1.06%
What is Amedisys' stock symbol?
Amedisys trades on the NASDAQ under the ticker symbol "AMED."
Where is Amedisys' stock going? Where will Amedisys' stock price be in 2017?
9 brokerages have issued 1 year price objectives for Amedisys' shares. Their predictions range from $47.00 to $60.00. On average, they anticipate Amedisys' share price to reach $52.29 in the next year.
When will Amedisys announce their earnings?
Amedisys is scheduled to release their next quarterly earnings announcement on Monday, March, 6th 2017.
Who owns Amedisys stock?
Amedisys' stock is owned by many different of retail and institutional investors. Top institutional shareholders include FMR LLC (6.55%), William Blair Investment Management LLC (4.50%), Dimensional Fund Advisors LP (4.13%), State Street Corp (2.06%), Cortina Asset Management LLC (0.98%) and Renaissance Technologies LLC (0.78%). Company insiders that own Amedisys stock include Bruce D Perkins, Donald A Washburn, Jeffrey D Jeter, North Tide Capital, Llc, Peter Ricchiuti and Scott G Ginn.
Who sold Amedisys stock? Who is selling Amedisys stock?
Amedisys' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Marshall Wace LLP, Systematic Financial Management LP, Dimensional Fund Advisors LP, Renaissance Technologies LLC, AQR Capital Management LLC, New York State Teachers Retirement System and Highland Capital Management LP.
Who bought Amedisys stock? Who is buying Amedisys stock?
Amedisys' stock was bought by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Cortina Asset Management LLC, State Street Corp, GSA Capital Partners LLP, Russell Investments Group Ltd., Denver Investment Advisors LLC, Trexquant Investment LP and Round Hill Asset Management.
How do I buy Amedisys stock?
Shares of Amedisys can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Amedisys stock cost?
One share of Amedisys stock can currently be purchased for approximately $48.91.